icon- folder.gif   Conference Reports for NATAP  
 
  13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil
 Back grey_arrow_rt.gif
 
 
 
Final assessment of real-world virological effectiveness of dolutegravir versus bictegravir triple regimens among people living with HIV and high viral load: the BicDol study in the French Dat'AIDS cohort
 
 
  Antoine CHERET, France
 
IAS 2026 Rio, Brazil
 

0728261copy

0728262copy

0728263copy

0728264copy

0728265copy

0728266copy

0728267copy